This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Astellas Pharma Gmbh. Active years: 2007-2008.
Company Filing History:
Years Active: 2007-2008
Title: The Innovations of Miyuki Katou
Introduction
Miyuki Katou is a prominent inventor based in Ibaraki, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents for type II diabetes. With a total of 2 patents, her work is recognized for its potential impact on health and medicine.
Latest Patents
Miyuki Katou's latest patents focus on a novel polypeptide that serves as a screening tool and method for identifying therapeutic agents aimed at alleviating insulin resistance in type II diabetes. These patents disclose a comprehensive approach that includes a polynucleotide, a vector, a promoter, and a transformant, all of which are instrumental in the screening process.
Career Highlights
Miyuki Katou is currently employed at Astellas Pharma GmbH, where she continues to innovate and contribute to the pharmaceutical industry. Her expertise in biotechnology and her dedication to research have positioned her as a valuable asset in her field.
Collaborations
Throughout her career, Miyuki has collaborated with notable colleagues, including Kunitake Abe and Noboru Yamaji. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic solutions.
Conclusion
Miyuki Katou's work exemplifies the spirit of innovation in the biotechnology sector. Her contributions to the development of therapeutic agents for type II diabetes highlight her commitment to improving health outcomes.